@PMLiVEcom profile picture
Pharmaceutical Market Europe @PMLiVEcom

News & analysis of healthcare, pharma and biotech. Magazines, directories, profiles, jobs & awards.

Joined June 2009
  • Tweets 22,137
  • Following 3,373
  • Followers 15,639
646 Photos and videos
Obesity care in the UK – why it can’t improve until it is recognised as a disease pmlive.com/obesity-care-in-t…

Obesity care in the UK – why it can’t improve until it is recognised as a disease - PMLiVE

The WHO classified obesity as a chronic disease over twenty years ago – but UK policy has yet to follow

pmlive.com
48
Novo Nordisk’s Wegovy approved as UK’s first daily GLP-1 weight loss pill pmlive.com/pharma_news/novo-…

Novo Nordisk’s Wegovy approved as UK's first daily GLP-1 weight loss pill - PMLiVE

The tablets will be available as a once-daily treatment, an alternative to weekly injections for adults with obesity, or overweight with a weight-related condition

pmlive.com
54
How to build a commercialisation strategy fit for biopharma’s new evidence era pmlive.com/pmhub/nmblr/how-t…

How to build a commercialisation strategy fit for biopharma's new evidence era - PMLiVE

The bar for evidence has never been higher. The EU's Joint Clinical Assessment process went live in January 2025, introducing harmonised clinical evidence requirements across member states. Regulat...

pmlive.com
1
61
Roche’s Tecentriq gets FDA Priority Review for specific stage 3 colon cancer pmlive.com/pharma_news/roche…

Roche’s Tecentriq gets FDA Priority Review for specific stage 3 colon cancer - PMLiVE

Over one million people are diagnosed globally each year and around 30% of stage 3 patients relapse within five years

pmlive.com
51
New benchmark reveals significant digital maturity gap across UK POM companies’ product-information estates pmlive.com/pmhub/genetic_dig…

New benchmark reveals significant digital maturity gap across UK POM companies’ product-information...

A new benchmark maps 100 UK prescription medicine companies across five maturity bands and finds a market at very different stages of digital development

pmlive.com
31
Lilly’s Ebglyss approved by FDA as maintenance dose for atopic dermatitis pmlive.com/pharma_news/lilly…

Lilly's Ebglyss approved by FDA as maintenance dose for atopic dermatitis - PMLiVE

This new option for patients allows for as few as six maintenance injections per year

pmlive.com
1
1
202
Where translation falls short in practice pmlive.com/pmhub/cuttsycutts…

Where translation falls short in practice - PMLiVE

Discover why translation alone is not enough in global clinical trials and how expert localisation improves participant understanding, trust and engagement.

pmlive.com
30
GSK to acquire biopharma Nuvalent for $10.6bn pmlive.com/pharma_news/gsk-t…

GSK to acquire biopharma Nuvalent for $10.6bn - PMLiVE

Two of Nuvalent’s NSCLC therapies have received FDA Breakthrough Therapy and Orphan Drug Designations

pmlive.com
64
Roche and Nurix Therapeutics to partner in $2.3bn deal pmlive.com/roche-and-nurix-t…

Roche and Nurix Therapeutics to partner in $2.3bn deal - PMLiVE

The companies will co-develop and co-commercialise bexobrutideg across malignant haematology, immunology and neurology

pmlive.com
62
Headline trade and market deals are opening doors to greater patient access pmlive.com/headline-trade-an…

Headline trade and market deals are opening doors to greater patient access - PMLiVE

Regulatory changes and tariffs have created a positive climate for investment, innovation and, critically, patient access to therapies

pmlive.com
48
Biogen’s salanersen gets FDA Breakthrough Therapy Designation for SMA pmlive.com/pharma_news/bioge…

Biogen’s salanersen gets FDA Breakthrough Therapy Designation for SMA - PMLiVE

In the study, there were improvements in motor function as well as a slowing of neurodegeneration

pmlive.com
86
Ardena appoints Ariane de Ganck as Chief Scientific Officer pmlive.com/pharma_appointmen…

Ardena appoints Ariane de Ganck as Chief Scientific Officer - PMLiVE

de Ganck was previously lead of the company’s Drug Product division

pmlive.com
1
55
Alnylam and Inceptive agree on $2bn AI collaboration pmlive.com/pharma_appointmen…

Alnylam and Inceptive agree on $2bn AI collaboration - PMLiVE

The deal will assist accelerate the discovery of RNAi therapeutics

pmlive.com
43
The Words Around Health Matter pmlive.com/pmhub/attigo_part…

The words around health matter - PMLiVE

The language used in healthcare can influence how people perceive their health, feel about themselves, and engage with treatments. Whole-person communication can help reduce stigma and support better...

pmlive.com
33
Bristol Myers Squibb and SystImmune announce phase 3 results for antibody-drug conjugate pmlive.com/pharma_news/brist…

Bristol Myers Squibb and SystImmune announce phase 3 results for antibody-drug conjugate - PMLiVE

The drug showed improvements in overall survival and progression-free survival in two cancers

pmlive.com
2
1
61
From activity to impact: 5 takeaways from MAPS Americas 2026 pmlive.com/pmhub/inizio/from…

From activity to impact: 5 takeaways from MAPS Americas 2026 - PMLiVE

Across sessions, panels, and conversations on the ground in Denver, there was a noticeable shift in both mindset and momentum. Many of the themes discussed in previous years are now being actively...

pmlive.com
55
Medscape Education Brings AI to the Hematology Frontline at EHA 2026 pmlive.com/pmhub/medscape_ed…

Medscape Education Brings AI to the Hematology Frontline at EHA 2026 - PMLiVE

Medscape Education is supporting a dedicated AI symposium at the 2026 European Hematology Association (EHA) Annual Congress in Stockholm on June 11, 2026.

pmlive.com
55
Gates Medical Research Institute appoints Charles Wells as Chief Medical Officer and Head of Medical Development pmlive.com/pharma_appointmen…

Gates Medical Research Institute appoints Charles Wells as Chief Medical Officer and Head of...

Wells previously served in executive leadership roles at Sanofi and Evotec

pmlive.com
58
J&J’s Erleada prostate cancer study shows significant reduction in risk of metastasis pmlive.com/pharma_news/jjs-e…

J&J’s Erleada prostate cancer study shows significant reduction in risk of metastasis - PMLiVE

Erleada plus hormone therapy significantly improved key short- and long-term clinical outcomes

pmlive.com
68
EMA celebrates diversity and inclusion in science and healthcare pmlive.com/pharma_news/ema-c…

EMA celebrates diversity and inclusion in science and healthcare - PMLiVE

The EU body underlines its commitment to diverse perspectives in medicines regulation

pmlive.com
33
Load more